inositol has been researched along with Acute Relapsing Multiple Sclerosis in 12 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
Excerpt | Relevance | Reference |
---|---|---|
"Citrulline was more frequently identified in the brains of patients with early-onset MS than in healthy subjects by (1)H-MR spectroscopy, suggesting an association of increased citrullination of myelin proteins with demyelinating diseases." | 5.14 | Assessment of citrullinated myelin by 1H-MR spectroscopy in early-onset multiple sclerosis. ( Aksu, AO; Anlar, B; Haspolat, S; Karabulut, E; Kurne, A; Kurul, S; Oguz, KK; Senbil, N; Serdaroglu, A; Teber, S, 2009) |
" Concentrations of glutamate + glutamin (Glx), cholin (Cho), myoinositol (mIns), N-acetyl aspartate (NAA) expressed as ratio with creatine (Cr) and NAA were correlated with markers of disease activity (RIO score), Multiple Sclerosis Severity Scale (MSSS), Depressive-Severity Status Scale and Simple Numerical Fatigue Scale." | 3.85 | Hypothalamic damage in multiple sclerosis correlates with disease activity, disability, depression, and fatigue. ( Baranovičová, E; Bittšanský, M; Čierny, D; Hnilicová, P; Kantorová, E; Kurča, E; Nosáľ, V; Poláček, H; Sivák, Š; Zeleňák, K, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (41.67) | 29.6817 |
2010's | 5 (41.67) | 24.3611 |
2020's | 2 (16.67) | 2.80 |
Authors | Studies |
---|---|
Tackley, G | 1 |
Kong, Y | 1 |
Minne, R | 1 |
Messina, S | 1 |
Winkler, A | 1 |
Cavey, A | 1 |
Everett, R | 1 |
DeLuca, GC | 1 |
Weir, A | 1 |
Craner, M | 1 |
Tracey, I | 1 |
Palace, J | 1 |
Stagg, CJ | 1 |
Emir, U | 1 |
Swanberg, KM | 1 |
Prinsen, H | 1 |
DeStefano, K | 1 |
Bailey, M | 1 |
Kurada, AV | 1 |
Pitt, D | 1 |
Fulbright, RK | 1 |
Juchem, C | 1 |
Kirov, II | 2 |
Liu, S | 1 |
Tal, A | 2 |
Wu, WE | 1 |
Davitz, MS | 1 |
Babb, JS | 2 |
Rusinek, H | 1 |
Herbert, J | 2 |
Gonen, O | 2 |
Moussallieh, FM | 1 |
Elbayed, K | 1 |
Chanson, JB | 1 |
Rudolf, G | 1 |
Piotto, M | 1 |
De Seze, J | 1 |
Namer, IJ | 1 |
Kantorová, E | 1 |
Poláček, H | 1 |
Bittšanský, M | 1 |
Baranovičová, E | 1 |
Hnilicová, P | 1 |
Čierny, D | 1 |
Sivák, Š | 1 |
Nosáľ, V | 1 |
Zeleňák, K | 1 |
Kurča, E | 1 |
Oguz, KK | 1 |
Kurne, A | 1 |
Aksu, AO | 1 |
Karabulut, E | 1 |
Serdaroglu, A | 1 |
Teber, S | 1 |
Haspolat, S | 1 |
Senbil, N | 1 |
Kurul, S | 1 |
Anlar, B | 1 |
Tur, C | 1 |
Wheeler-Kingshott, CA | 1 |
Altmann, DR | 2 |
Miller, DH | 3 |
Thompson, AJ | 2 |
Ciccarelli, O | 1 |
Tiberio, M | 1 |
Chard, DT | 1 |
Davies, G | 1 |
Griffin, CM | 1 |
McLean, MA | 1 |
Rashid, W | 1 |
Sastre-Garriga, J | 1 |
Summers, M | 1 |
Swanton, J | 1 |
Fernando, K | 1 |
Dalton, C | 1 |
Cipolotti, L | 1 |
Ron, MA | 1 |
Mader, I | 1 |
Roser, W | 1 |
Kappos, L | 1 |
Hagberg, G | 1 |
Seelig, J | 1 |
Radue, EW | 1 |
Steinbrich, W | 1 |
Pozdniakov, AV | 1 |
Tiutin, LA | 1 |
Bisaga, GN | 1 |
Odinak, MM | 1 |
2 trials available for inositol and Acute Relapsing Multiple Sclerosis
Article | Year |
---|---|
Assessment of citrullinated myelin by 1H-MR spectroscopy in early-onset multiple sclerosis.
Topics: Adolescent; Age of Onset; Aspartic Acid; Child; Child, Preschool; Choline; Citrulline; Creatine; Dem | 2009 |
Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2 years during a clinical pharmacological study.
Topics: Adult; Aspartic Acid; Brain; Choline; Creatine; Female; Follow-Up Studies; Guanidines; Humans; Image | 2000 |
10 other studies available for inositol and Acute Relapsing Multiple Sclerosis
Article | Year |
---|---|
An In-vivo 1H-MRS short-echo time technique at 7T: Quantification of metabolites in chronic multiple sclerosis and neuromyelitis optica brain lesions and normal appearing brain tissue.
Topics: Adult; Aquaporin 4; Aspartic Acid; Autoantibodies; Autoantigens; Brain Chemistry; Female; Gliosis; G | 2021 |
In vivo evidence of differential frontal cortex metabolic abnormalities in progressive and relapsing-remitting multiple sclerosis.
Topics: Adult; Aged; Aspartic Acid; Choline; Female; Frontal Lobe; gamma-Aminobutyric Acid; Glutamine; Gluta | 2021 |
Proton MR spectroscopy of lesion evolution in multiple sclerosis: Steady-state metabolism and its relationship to conventional imaging.
Topics: Adult; Aspartic Acid; Brain; Choline; Creatine; Cross-Sectional Studies; Disease Progression; Female | 2017 |
Serum analysis by 1H nuclear magnetic resonance spectroscopy: a new tool for distinguishing neuromyelitis optica from multiple sclerosis.
Topics: Acetic Acid; Adult; Astrocytes; Biomarkers; Case-Control Studies; Diagnosis, Differential; Discrimin | 2014 |
Hypothalamic damage in multiple sclerosis correlates with disease activity, disability, depression, and fatigue.
Topics: Adult; Aging; Aspartic Acid; Case-Control Studies; Choline; Creatine; Cross-Sectional Studies; Depre | 2017 |
Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS.
Topics: Adult; Aspartic Acid; Brain; Case-Control Studies; Choline; Creatine; Disability Evaluation; Female; | 2013 |
Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSI.
Topics: Adult; Aged; Choline; Disability Evaluation; Humans; Hydrogen; Inositol; Magnetic Resonance Imaging; | 2014 |
Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study.
Topics: Adult; Aspartic Acid; Choline; Creatine; Dipeptides; Female; Follow-Up Studies; Glutamic Acid; Human | 2006 |
Cognitive impairment in multiple sclerosis can be predicted by imaging early in the disease.
Topics: Adolescent; Adult; Aspartic Acid; Atrophy; Brain; Cerebral Ventricles; Cognition Disorders; Cohort S | 2008 |
[Proton magnetic-resonance spectroscopy in remitting and secondary-progressive multiple sclerosis].
Topics: Adolescent; Adult; Aspartic Acid; Brain; Choline; Creatine; Demyelinating Diseases; Female; gamma-Am | 2001 |